1 asset in Reversible Cerebral Vasoconstriction Syndrome

Therapeutic assets addressing Reversible Cerebral Vasoconstriction Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Onabotulinum Toxin A Reversible Cerebral Vasoconstriction Syndrome	University of Alberta	P1	CC (43)